GeneLink Inc. announced earnings results for the fiscal year ended December 31, 2012. For the year, annual net sales decreased from $4,684,577 to $2,136,142. The decrease is primarily related to the sale of GeneWize and the subsequent conversion from retail to wholesale business model in February of 2012.

The operating loss in 2012 was $3,468,997. Most of the loss is attributable to the unsupported overhead costs at company, establishment of GeneLink's own manufacturing facility, and implementation of plans to support company's expansion into additional channels. Net losses for 2012 in the amount of $3,051,747 decreased by $748,449 or 20% compared to 2011.